A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects

Clinical trial NCT05943886 · COMPLETED

Trial details

NCT number: NCT05943886
Sponsor: Dongguan HEC Biopharmaceutical R&D Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Obesity T2DM (Type 2 Diabetes Mellitus)

Start date: 2021-08-11
Primary completion: 2023-02-17
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.